{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:21:55Z","timestamp":1773274915735,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15564-8","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:06:33Z","timestamp":1769738793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Axillary staging in post-neoadjuvant chemotherapy breast cancer patients: prognostic analysis and validation of axillary nodal metrics and comparison of the pathological node staging versus the lymph node ratio systems in a 169-case series"],"prefix":"10.1186","volume":"26","author":[{"given":"Amin","family":"Safavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narjes","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Kaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Dadashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atousa","family":"Dadashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"4","key":"15564_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.21037\/atm-20-4856","volume":"9","author":"MS Wang","year":"2021","unstructured":"Wang MS, Wang MZ, Wang Z, Song Y, Gao P, Wang P, et al. Comparison of three lymph node staging methods for predicting outcome in breast cancer patients with mastectomy. Ann Transl Med. 2021;9(4):300.","journal-title":"Ann Transl Med"},{"key":"15564_CR2","doi-asserted-by":"publisher","unstructured":"\u00d6zkavruk Eliyatk\u0131n N, Ba\u015fk\u0131r \u0130, \u0130\u015flek A, Zengel B. New lymph node parameters and a comparison with the American joint committee on cancer N-Stages in breast cancer. Cyprus J Med Sci. 2023;8(4):276\u201386.\u00a0https:\/\/doi.org\/10.4274\/cjms.2023.2023-34.","DOI":"10.4274\/cjms.2023.2023-34"},{"issue":"4","key":"15564_CR3","first-page":"290","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, et al. Breast cancer-Major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290\u2013303.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"15564_CR4","first-page":"110","volume":"4","author":"A Safavi","year":"2017","unstructured":"Safavi A, Kaviani A, Mohammadzadeh N, Zand S, Elahi A, Krag D. Breast cancer prognostication by pathologic node staging (pN-staging) system versus lymph node ratio (LNR): A critical review of conflicts with number of nodes, Z-0011 Trial, staging Cut-points, Neo-adjuvant Therapy, and survival Estimation. Archives Breast Cancer. 2017;4(4):110\u201323.","journal-title":"Archives Breast Cancer"},{"issue":"3","key":"15564_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/0109298665339026250114070523","volume":"32","author":"X Li","year":"2025","unstructured":"Li X, Liu J, He L, Tian M, Xu Y, Peng B. miR-584-5p regulates MSMO1 to modulate the AKT\/PI3K pathway and inhibit breast cancer progression. Protein Pept Lett. 2025;32(3):171\u201382.","journal-title":"Protein Pept Lett"},{"key":"15564_CR6","doi-asserted-by":"crossref","unstructured":"Jin H, Wan M, Pan S, Wang Z, Wang W, Zhang J, et al. CD1B expression in triple-negative breast cancer: its implications for prognosis and immunotherapy outcomes. Curr Gene Ther. 2025. Epub ahead of print.","DOI":"10.2174\/0115665232364481250131071311"},{"key":"15564_CR7","doi-asserted-by":"publisher","first-page":"1169010","DOI":"10.3389\/fonc.2023.1169010","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Qi Y, Wang K. Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress. Front Oncol. 2023;13:1169010.","journal-title":"Front Oncol"},{"issue":"2","key":"15564_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-011-1730-9","volume":"130","author":"SH Ahn","year":"2011","unstructured":"Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, et al. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat. 2011;130(2):507\u201315.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"15564_CR9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00404-014-3528-6","volume":"291","author":"B Ataseven","year":"2015","unstructured":"Ataseven B, K\u00fcmmel S, Weikel W, Heitz F, Holtschmidt J, Lorenz-Salehi F, et al. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients. Arch Gynecol Obstet. 2015;291(5):1153\u201366.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"15564_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1245\/s10434-013-3245-6","volume":"21","author":"S Chen","year":"2014","unstructured":"Chen S, Liu Y, Huang L, Chen CM, Wu J, Shao ZM. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging. Ann Surg Oncol. 2014;21(1):42\u201350.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"15564_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00432-014-1810-4","volume":"141","author":"YL Chen","year":"2015","unstructured":"Chen YL, Wang CY, Wu CC, Lee MS, Hung SK, Chen WC, et al. Prognostic influences of lymph node ratio in major cancers of taiwan: a longitudinal study from a single cancer center. J Cancer Res Clin Oncol. 2015;141(2):333\u201343.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"15564_CR12","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1245\/s10434-013-2932-7","volume":"20","author":"PJ Dings","year":"2013","unstructured":"Dings PJ, Elferink MA, Strobbe LJ, de Wilt JH. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study. Ann Surg Oncol. 2013;20(8):2607\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"15564_CR13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00268-013-1965-1","volume":"37","author":"N Duraker","year":"2013","unstructured":"Duraker N, Bati B, \u00c7aynak ZC, Demir D. Lymph node ratio May be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients. World J Surg. 2013;37(6):1241\u20138.","journal-title":"World J Surg"},{"issue":"3","key":"15564_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after Sentinel lymph node dissection with or without axillary dissection in patients with Sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u201332. discussion 32\u2009\u2013\u20093.","journal-title":"Ann Surg"},{"issue":"4","key":"15564_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13193-011-0062-x","volume":"1","author":"HA Hatoum","year":"2010","unstructured":"Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, et al. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Indian J Surg Oncol. 2010;1(4):305\u201312.","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"15564_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1743-7563.2010.01288.x","volume":"6","author":"EM Ibrahim","year":"2010","unstructured":"Ibrahim EM, Elkhodary TR, Zekri JM, Bahadur Y, El-Sayed ME, Al-Gahmi AM, et al. Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Asia Pac J Clin Oncol. 2010;6(2):130\u20137.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"2","key":"15564_CR17","first-page":"143","volume":"84","author":"A Inal","year":"2013","unstructured":"Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, et al. Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian society of medical oncology. Ann Ital Chir. 2013;84(2):143\u20138.","journal-title":"Ann Ital Chir"},{"issue":"4","key":"15564_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.4143\/crt.2015.475","volume":"48","author":"SH Kim","year":"2016","unstructured":"Kim SH, Jung KH, Kim TY, Im SA, Choi IS, Chae YS, et al. Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of Doxorubicin\/Cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study. Cancer Res Treat. 2016;48(4):1373\u201381.","journal-title":"Cancer Res Treat"},{"issue":"5","key":"15564_CR19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/bjc.2013.465","volume":"109","author":"SI Kim","year":"2013","unstructured":"Kim SI, Cho SH, Lee JS, Moon HG, Noh WC, Youn HJ, et al. Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes. Br J Cancer. 2013;109(5):1165\u201371.","journal-title":"Br J Cancer"},{"issue":"9","key":"15564_CR20","doi-asserted-by":"publisher","first-page":"e45809","DOI":"10.1371\/journal.pone.0045809","volume":"7","author":"N Saxena","year":"2012","unstructured":"Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, Taib NA, et al. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? PLoS ONE. 2012;7(9):e45809.","journal-title":"PLoS ONE"},{"issue":"6","key":"15564_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.clbc.2012.07.009","volume":"12","author":"F Wang","year":"2012","unstructured":"Wang F, He W, Qiu H, Wang X, Guo G, Chen X, et al. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer. Clin Breast Cancer. 2012;12(6):404\u201311.","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"15564_CR22","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.7314\/APJCP.2013.14.9.5219","volume":"14","author":"XS Xiao","year":"2013","unstructured":"Xiao XS, Tang HL, Xie XH, Li LS, Kong YN, Wu MQ, et al. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer\u2013results for 804 Chinese patients from a single institution. Asian Pac J Cancer Prev. 2013;14(9):5219\u201323.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"15564_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5230\/jgc.2021.21.e5","volume":"21","author":"K Zhu","year":"2021","unstructured":"Zhu K, Jin H, Li Z, Gao Y, Zhang Q, Liu X, et al. The prognostic value of lymph node ratio after neoadjuvant chemotherapy in patients with locally advanced gastric adenocarcinoma. J Gastric Cancer. 2021;21(1):49\u201362.","journal-title":"J Gastric Cancer"},{"issue":"8","key":"15564_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ejca.2010.12.009","volume":"47","author":"N Saxena","year":"2011","unstructured":"Saxena N, Hartman M, Aziz R, Rapiti E, Bhoo Pathy N, Lim SE, et al. Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study. Eur J Cancer. 2011;47(8):1186\u201392.","journal-title":"Eur J Cancer"},{"key":"15564_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2407-14-4","volume":"14","author":"T Erbes","year":"2014","unstructured":"Erbes T, Orlowska-Volk M, Zur Hausen A, R\u00fccker G, Mayer S, Voigt M, et al. Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection. BMC Cancer. 2014;14:4.","journal-title":"BMC Cancer"},{"issue":"10","key":"15564_CR26","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1245\/s10434-016-5319-8","volume":"23","author":"J Tsai","year":"2016","unstructured":"Tsai J, Bertoni D, Hernandez-Boussard T, Telli ML, Wapnir IL. Lymph node ratio analysis after neoadjuvant chemotherapy is prognostic in hormone Receptor-Positive and Triple-Negative breast cancer. Ann Surg Oncol. 2016;23(10):3310\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"15564_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4143\/crt.2014.039","volume":"47","author":"SG Wu","year":"2015","unstructured":"Wu SG, Li Q, Zhou J, Sun JY, Li FY, Lin Q, et al. Using the lymph node ratio to evaluate the prognosis of stage II\/III breast cancer patients who received neoadjuvant chemotherapy and mastectomy. Cancer Res Treat. 2015;47(4):757\u201364.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"15564_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","volume":"3","author":"M Pilewskie","year":"2017","unstructured":"Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: A review. JAMA Oncol. 2017;3(4):549\u201355.","journal-title":"JAMA Oncol"},{"issue":"1","key":"15564_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-013-0497-8","volume":"21","author":"D Liu","year":"2014","unstructured":"Liu D, Chen Y, Deng M, Xie G, Wang J, Zhang L, et al. Lymph node ratio and breast cancer prognosis: a meta-analysis. Breast Cancer. 2014;21(1):1\u20139.","journal-title":"Breast Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15564-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:02:27Z","timestamp":1773223347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15564-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15564"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15564-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the ethics board of Tehran University of Medical Sciences. Written informed consent was obtained from all patients at the time of admission for participation in research and use of their anonymized data, in accordance with institutional protocols. All procedures were performed in compliance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as this study does not contain any individual person\u2019s data in any form (e.g., images, videos, or identifiable details). The ethics board of Tehran University of Medical Sciences confirmed that consent for publication was not required due to the anonymized and retrospective nature of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}